UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (18), p.9299-9307

2006

Volltextzugriff (PDF)

Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma

Journal of clinical oncology, 2011-06, Vol.29 (17), p.2350-2356

2011

Volltextzugriff (PDF)

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia

EBioMedicine, 2015-12, Vol.2 (12), p.1987-1995

2015

Volltextzugriff (PDF)

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2319-2333

2001

Volltextzugriff (PDF)

A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)

Clinical breast cancer, 2022-02, Vol.22 (2), p.103-114

2022

Volltextzugriff (PDF)

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT

Investigational new drugs, 2011-12, Vol.29 (6), p.1381-1389

2011

Volltextzugriff (PDF)

Clinical pharmacology of flavopiridol following a 72-hour continuous infusion

The Annals of pharmacotherapy, 2003-10, Vol.37 (10), p.1369-1374

2003

Volltextzugriff (PDF)

Phase I Study of the Taxane BMS-188797 in Combination with Carboplatin Administered Every 3 Weeks in Patients with Solid Malignancies

Clinical cancer research, 2006-01, Vol.12 (2), p.523-528

2006

Volltextzugriff (PDF)

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies

Clinical cancer research, 2005-05, Vol.11 (9), p.3335-3341

2005

Volltextzugriff (PDF)

Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.2130-2137

2006

Volltextzugriff (PDF)

Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target

The Annals of pharmacotherapy, 1997-01, Vol.31 (1), p.76-82

1997

Volltextzugriff (PDF)

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies

Cancer medicine (Malden, MA), 2016-02, Vol.5 (2), p.294-303

2016

Volltextzugriff (PDF)

Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates

Clinical cancer research, 2011-12, Vol.17 (24), p.7743-7753

2011

Volltextzugriff (PDF)

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer

Cancer chemotherapy and pharmacology, 2012-10, Vol.70 (4), p.567-574

2012

Volltextzugriff (PDF)

The absolute bioavailability of oral vinorelbine in patients with solid tumors

Cancer chemotherapy and pharmacology, 2005-12, Vol.56 (6), p.578-584

2005

Volltextzugriff (PDF)

A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer

Tumori, 1998-01, Vol.84 (1), p.87-89

1998

Volltextzugriff (PDF)

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Journal of clinical oncology, 1998-09, Vol.16 (9), p.2986-2999

1998

Volltextzugriff (PDF)

Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis

Journal of clinical pharmacology, 1999-04, Vol.39 (4), p.394-401

1999

Volltextzugriff (PDF)

The Mutated Androgen Receptor and Its Implications for the Treatment of Metastatic Carcinoma of the Prostate

Pharmacotherapy, 1996-05, Vol.16 (3), p.376-381

1996

Volltextzugriff (PDF)

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer

Journal of investigative medicine, 1998-02, Vol.46 (2), p.66

1998

Volltextzugriff (PDF)

Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration : Use of a single model for simultaneous determination of changing parameters

Journal of pharmacokinetics and biopharmaceutics, 1998-12, Vol.26 (6), p.673-687

1998

Volltextzugriff (PDF)

Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer

Acta oncologica, 1996, Vol.35 (6), p.763-765

1996

Volltextzugriff (PDF)

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

Blood, 1996-08, Vol.88 (4), p.1188-1197

1996

Volltextzugriff (PDF)

The Turkey Gets the Last Laugh

Canadian journal of general internal medicine, 2016-02, Vol.8 (1)

Lush MD, Richard B.

2016

Volltextzugriff (PDF)

Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients

Radiology, 1994-11, Vol.193 (2), p.513-517

1994

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(76)
Reviews
(1)

Sprache

Englisch
(77)

Erscheinungsjahr

n.n

Thema

Humans
(58)
Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Male
(46)
Biological And Medical Sciences
(43)
Medical Sciences
(41)
Middle Aged
(41)
Female
(38)
Adult
(33)
Aged
(32)
Pharmacology. Drug Treatments
(30)
Antineoplastic Agents
(28)
Oncology
(28)
Chemotherapy
(19)
Pharmacology & Pharmacy
(19)
Neoplasms - Drug Therapy
(18)
Treatment Outcome
(14)
Dose-Response Relationship, Drug
(12)
Aged, 80 And Over
(10)
Antineoplastic Agents - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

Phase II Study of the Mitogen-Activated Protein Kinase 1/2 Inhibitor Selumetinib in Patients With Advanced Hepatocellular Carcinoma

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia

Phase I Trial of 72-Hour Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC)

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT

Clinical pharmacology of flavopiridol following a 72-hour continuous infusion

Phase I Study of the Taxane BMS-188797 in Combination with Carboplatin Administered Every 3 Weeks in Patients with Solid Malignancies

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies

Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial

Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target

Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignancies

Phase I Study of Topotecan, Ifosfamide, and Etoposide (TIME) with Autologous Stem Cell Transplant in Refractory Cancer: Pharmacokinetic and Pharmacodynamic Correlates

A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer

The absolute bioavailability of oral vinorelbine in patients with solid tumors

A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancer

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms

Pharmacokinetics of Cisplatin Administered by Continuous Hyperthermic Peritoneal Perfusion (CHPP) to Patients with Peritoneal Carcinomatosis

The Mutated Androgen Receptor and Its Implications for the Treatment of Metastatic Carcinoma of the Prostate

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer

Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration : Use of a single model for simultaneous determination of changing parameters

Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

The Turkey Gets the Last Laugh

Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients

Suchergebnisse filtern